SRPIN340

CAS No. 218156-96-8

SRPIN340( SRPK Inhibitor )

Catalog No. M13482 CAS No. 218156-96-8

SRPIN340 is a serine/arginine-rich protein kinase (SRPK)-specific inhibitor with an IC50 value of 0.89 uM (SRPK1).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 65 In Stock
2MG 37 In Stock
5MG 60 In Stock
10MG 102 In Stock
25MG 187 In Stock
50MG 335 In Stock
100MG 435 In Stock
200MG Get Quote In Stock
500MG 977 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SRPIN340
  • Note
    Research use only, not for human use.
  • Brief Description
    SRPIN340 is a serine/arginine-rich protein kinase (SRPK)-specific inhibitor with an IC50 value of 0.89 uM (SRPK1).
  • Description
    SRPIN340 is a serine/arginine-rich protein kinase (SRPK)-specific inhibitor with an IC50 value of 0.89 uM (SRPK1); no significant inhibitory activity against more than 140 other kinases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SRPK Inhibitor
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Serine Protease
  • Recptor
    SRPK1
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    218156-96-8
  • Formula Weight
    349.35
  • Molecular Formula
    C18H18F3N3O
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 70 mg/mL (200.37 mM); DMSO: 70 mg/mL (200.37 mM)
  • SMILES
    O=C(C1=CC=NC=C1)NC2=CC(C(F)(F)F)=CC=C2N3CCCCC3
  • Chemical Name
    N-(2-(piperidin-1-yl)-5-(trifluoromethyl)phenyl)isonicotinamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Fukuhara T, et al. Proc Natl Acad Sci U S A. 2006, 103(30), 11329-11333.
molnova catalog
related products
  • Demethylwedelolacton...

    Demethylwedelolactone is a natural product isolated from Eclipta alba,?has trypsin inhibitory effect an IC50 of 3.0 μM. it exerts anti-invasive growth effect on breast cancer cells.demethylwedelolactone (DWEL) inhibited the anchorage-independent growth and also suppressed cell motility and cell invasion of MDA-MB-231 cells.

  • ENMD-1068 HCl

    ENMD-1068 is a PAR-2 antagonist. ENMD-1068 inhibits the development of endometriosis in a mouse model.

  • Upamostat

    Upamostat is an inhibitor of a serine protease and is a urokinase plasminogen activator (uPA) inhibitor.